Nuclear imaging is evolving as a next frontier in the medical imaging
industry. Nuclear imaging gained significant importance in medical
industry space by understanding physiology of disease that helps in
addressing the disease at early stages with faster and accurate
diagnosis.

There is an increased adoption of nuclear imaging due to the
developments of novel radiopharmaceuticals in new clinical areas like
orthopaedics and neurology when compared to traditionally used clinical
areas like oncology and cardiology. However, the nuclear imaging
industry is poised to face challenges like decreased federal support,
heavy regulatory requirements, inadequate supply of radionuclides for
research, etc. This report is key for strategies that can be employed
the market participants to address the industry challenges.

The analysis would be key for the new entrants and established market
players to create viable and implementable strategies to ensure
continued innovations and stay competitive in the nuclear imaging
industry. This research service sheds light on the nuclear imaging
technology landcape, key growth opportunities for research and
development, associated regulatory and technology challenges and their
corresponding recommendations, key company profiling, and intellectual
property landscape.